{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:35:59Z","timestamp":1793352959294,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Primary percutaneous coronary intervention (PCI) of the culprit lesion is the preferred treatment in ST-segment elevation myocardial infarction (STEMI). However, in nearly half of all patients, multivessel coronary artery disease is present, raising fundamental questions: should non-culprit lesions be treated at all, and if so, should revascularization be performed immediately or in a staged fashion? Furthermore, should lesion selection be guided by angiography or by functional and imaging-based assessment? Over the past decade, landmark trials shifted clinical practice and formed the basis for current guideline recommendations of the European Society of Cardiology, advocating routine complete revascularization within 45 days in all hemodynamically stable patients. Yet, recently published evidence has challenged this paradigm. New randomized trials exploring the timing and guidance of non-culprit lesion PCI have yielded heterogeneous and, at times, conflicting results. While some suggest that immediate complete revascularization is safe, others raise concerns in patients with impaired cardiac function. Another recently published trial introduces a novel concept by directly comparing immediate physiology-guided PCI with a staged, noninvasive ischemia-guided strategy, demonstrating similar long-term outcomes with substantially fewer interventions. Together, these findings are reshaping the current view of the management of multivessel disease in STEMI. The metaphoric \u2018therapeutic pendulum\u2019 \u2013 after swinging firmly towards immediate complete revascularization \u2013 is beginning to swing back towards a more individualized, physiology- and imaging-based approach. The central aim of this review is to evaluate whether this individualized staged physiology- and imaging-based approach is a valid alternative to immediate complete revascularization. Clarifying which patients truly benefit from immediate complete revascularization remains a pivotal challenge for future clinical research and guideline development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001661","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:00:33Z","timestamp":1783609233000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients"],"prefix":"10.1097","volume":"37","author":[{"given":"Tim","family":"Heller","sequence":"first","affiliation":[{"name":"Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffi","family":"Bekeredjian","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction.","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehm184","article-title":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.","volume":"28","author":"Sorajja","year":"2007","journal-title":"Eur Heart J"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2006.06.010","article-title":"Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion.","volume":"98","author":"van der Schaaf","year":"2006","journal-title":"Am J Cardiol"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock.","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction.","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014PRIMULTI): an open-label, randomised controlled trial.","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2025.05.013","article-title":"10-year outcome of complete or infarct artery-only revascularization in STEMI with multivessel disease: the DANAMI-3-PRIMULTI study.","volume":"86","author":"Marquard","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction.","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2104650","article-title":"Multivessel PCI guided by FFR or angiography for myocardial infarction.","volume":"385","author":"Puymirat","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ehjqcco\/qcaa012","article-title":"Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction?","volume":"6","author":"Wald","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ehjqcco\/qcaa007","article-title":"Angiography- vs. physiology-guided complete revascularization in patients with ST-elevation myocardial infarction and multivessel disease: who is the better gatekeeper in this setting? A meta-analysis of randomized controlled trials.","volume":"6","author":"Gallone","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"e004296","DOI":"10.1161\/CIRCINTERVENTIONS.116.004296","article-title":"Impact of routine fractional flow reserve on management decision and 1-year clinical outcome of patients with acute coronary syndromes.","volume":"10","author":"Van Belle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jcin.2011.08.008","article-title":"Fractional flow reserve in unstable angina and non\u2013ST-segment elevation myocardial infarction.","volume":"4","author":"Sels","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jcmg.2022.04.026","article-title":"Clinical utility of intravascular imaging: past, present, and future.","volume":"15","author":"Mintz","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","article-title":"Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.","volume":"40","author":"Johnson","year":"2019","journal-title":"Eur Heart J"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"e008768","DOI":"10.1161\/CIRCINTERVENTIONS.119.008768","article-title":"Nonculprit lesion plaque morphology in patients with ST-segment\u2013elevation myocardial infarction.","volume":"13","author":"Pinilla-Echeverri","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamacardio.2023.2910","article-title":"Fractional flow reserve-negative high-risk plaques and clinical outcomes after myocardial infarction.","volume":"8","author":"Mol","year":"2023","journal-title":"JAMA Cardiol"},{"key":"R21-20261030","first-page":"86","article-title":"Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention.","volume":"75","author":"Maluenda","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"e023481","DOI":"10.1161\/JAHA.121.023481","article-title":"Role of intravascular ultrasound-guided percutaneous coronary intervention in optimizing outcomes in acute myocardial infarction.","volume":"11","author":"Kim","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.jcin.2021.08.021","article-title":"Impact of intravascular ultrasound on long-term clinical outcomes in patients with acute myocardial infarction.","volume":"14","author":"Choi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"R24-20261030","first-page":"696","article-title":"Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.","volume":"95","author":"Kim","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.3390\/jcm12185892","article-title":"The usefulness of intracoronary imaging in patients with ST-segment elevation myocardial infarction.","volume":"12","author":"Karamasis","year":"2023","journal-title":"J Clin Med"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa2307823","article-title":"Timing of complete revascularization with multivessel PCI for myocardial infarction.","volume":"389","author":"St\u00e4hli","year":"2023","journal-title":"N Engl J Med"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(23)00351-3","article-title":"Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.","volume":"401","author":"Diletti","year":"2023","journal-title":"Lancet"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(25)01529-6","article-title":"Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.","volume":"406","author":"Kim","year":"2025","journal-title":"Lancet"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jchf.2022.02.008","article-title":"Acute decompensated heart failure in the setting of acute coronary syndrome.","volume":"10","author":"Harrington","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2512918","article-title":"Immediate or deferred nonculprit-lesion PCI in myocardial infarction.","volume":"394","author":"Nijveldt","year":"2025","journal-title":"N Engl J Med"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.jcin.2017.07.021","article-title":"Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with ST-segment elevation myocardial infarction.","volume":"10","author":"Thim","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI.","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"e070561","DOI":"10.1136\/bmjopen-2022-070561","article-title":"Risk factors associated with contrast-associated acute kidney injury in ST-segment elevation myocardial infarction patients: a systematic review and meta-analysis.","volume":"13","author":"Ye","year":"2023","journal-title":"BMJ Open"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.25270\/jic\/23.00007","article-title":"Incidence, treatment and outcomes of coronary artery dissection during percutaneous coronary intervention.","volume":"35","author":"Page","year":"2023","journal-title":"J Invasive Cardiol"},{"key":"R36-20261030","first-page":"1682","article-title":"Incidence and influencing factors of in-stent restenosis after percutaneous coronary intervention in patients with coronary artery disease: a systematic review and meta-analysis.","volume":"106","author":"Wu","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MCA.0000000000001157","article-title":"Management of patients with ST-segment myocardial infarction and multivessel disease: what are the options in 2022?","volume":"33","author":"Ong","year":"2022","journal-title":"Coron Artery Dis"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:02:23Z","timestamp":1793350943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001661","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2026-05-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}